{"title":"Botanical Study of Berberis vulgaris L of Family Berberidaceae: A Review","authors":"Diksha Sharma, K. Jeet, Sanjay Kumar","doi":"10.52711/0975-4385.2024.00011","DOIUrl":null,"url":null,"abstract":"The interest in natural and functional food products has increased globally. This review will add to the growing literature for the researchers. The Berberry or Berberis vulgaris, are has a place with the Berberidaceae family which is red shaded organic products developing in the Europe and Asia. A large body of literature supports different pharmacological actions of Berberis vulgaris (B. vulgaris) and its active component, berberine (BBR), such as antidiabetic, antiobesity, hypotensive and hypolipidemic properties that could be interesting in the management of CVD risk. Numerous preclinical in vitro and in vivo studies support all these effects. In this review, we evaluated the most related original articles to discover the role of B. vulgaris on various constituents. This review suggests a potential role of Berberis vulgaris.","PeriodicalId":21071,"journal":{"name":"Research Journal of Pharmacognosy and Phytochemistry","volume":"30 15","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-02-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Research Journal of Pharmacognosy and Phytochemistry","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.52711/0975-4385.2024.00011","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
The interest in natural and functional food products has increased globally. This review will add to the growing literature for the researchers. The Berberry or Berberis vulgaris, are has a place with the Berberidaceae family which is red shaded organic products developing in the Europe and Asia. A large body of literature supports different pharmacological actions of Berberis vulgaris (B. vulgaris) and its active component, berberine (BBR), such as antidiabetic, antiobesity, hypotensive and hypolipidemic properties that could be interesting in the management of CVD risk. Numerous preclinical in vitro and in vivo studies support all these effects. In this review, we evaluated the most related original articles to discover the role of B. vulgaris on various constituents. This review suggests a potential role of Berberis vulgaris.
全球对天然和功能性食品的兴趣与日俱增。本综述将为研究人员提供更多的文献资料。红叶小檗(Berberry or Berberis vulgaris)属于小檗科,是欧洲和亚洲开发的红色阴影有机产品。大量文献证实了小檗(B. vulgaris)及其活性成分小檗碱(BBR)的不同药理作用,如抗糖尿病、抗肥胖、降血压和降血脂特性,这些特性可能对控制心血管疾病风险很有意义。大量的临床前体外和体内研究支持所有这些作用。在这篇综述中,我们评估了最相关的原创文章,以发现 B. vulgaris 对各种成分的作用。本综述提出了小檗的潜在作用。